Erratum: Heregulin inhibits proliferation via ERKs and phosphatidyl inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells (International Journal of Cancer (2002) 100 (642-653))

L. Puricelli; Cecilia J. Proietti; L. Labriola; M. Salatino; M. E. Balana; J. Aguirre Ghiso; R. Lupu; O. P. Pignataro; E. H. Charreau; E. Bal De Kier Joffe; P. V. Elizalde

doi:10.1002/ijc.21414

Erratum: Heregulin inhibits proliferation via ERKs and phosphatidyl inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells (International Journal of Cancer (2002) 100 (642-653))

L. Puricelli, Cecilia J. Proietti, L. Labriola, M. Salatino, M. E. Balana, J. Aguirre Ghiso, R. Lupu, O. P. Pignataro, E. H. Charreau, E. Bal De Kier Joffe, P. V. Elizalde

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1065
Number of pages	1
Journal	International Journal of Cancer
Volume	117
Issue number	6
DOIs	https://doi.org/10.1002/ijc.21414
State	Published - 20 Dec 2005

Access to Document

10.1002/ijc.21414

Cite this

Puricelli, L., Proietti, C. J., Labriola, L., Salatino, M., Balana, M. E., Aguirre Ghiso, J., Lupu, R., Pignataro, O. P., Charreau, E. H., Bal De Kier Joffe, E., & Elizalde, P. V. (2005). Erratum: Heregulin inhibits proliferation via ERKs and phosphatidyl inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells (International Journal of Cancer (2002) 100 (642-653)). International Journal of Cancer, 117(6), 1065. https://doi.org/10.1002/ijc.21414

Puricelli, L. ; Proietti, Cecilia J. ; Labriola, L. et al. / Erratum : Heregulin inhibits proliferation via ERKs and phosphatidyl inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells (International Journal of Cancer (2002) 100 (642-653)). In: International Journal of Cancer. 2005 ; Vol. 117, No. 6. pp. 1065.

@article{a26f1c321cfb42d6b67c63129183ee1a,

title = "Erratum: Heregulin inhibits proliferation via ERKs and phosphatidyl inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells (International Journal of Cancer (2002) 100 (642-653))",

author = "L. Puricelli and Proietti, {Cecilia J.} and L. Labriola and M. Salatino and Balana, {M. E.} and {Aguirre Ghiso}, J. and R. Lupu and Pignataro, {O. P.} and Charreau, {E. H.} and {Bal De Kier Joffe}, E. and Elizalde, {P. V.}",

year = "2005",

month = dec,

day = "20",

doi = "10.1002/ijc.21414",

language = "English",

volume = "117",

pages = "1065",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

Puricelli, L, Proietti, CJ, Labriola, L, Salatino, M, Balana, ME, Aguirre Ghiso, J, Lupu, R, Pignataro, OP, Charreau, EH, Bal De Kier Joffe, E & Elizalde, PV 2005, 'Erratum: Heregulin inhibits proliferation via ERKs and phosphatidyl inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells (International Journal of Cancer (2002) 100 (642-653))', International Journal of Cancer, vol. 117, no. 6, pp. 1065. https://doi.org/10.1002/ijc.21414

Erratum: Heregulin inhibits proliferation via ERKs and phosphatidyl inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells (International Journal of Cancer (2002) 100 (642-653)). / Puricelli, L.; Proietti, Cecilia J.; Labriola, L. et al.
In: International Journal of Cancer, Vol. 117, No. 6, 20.12.2005, p. 1065.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Heregulin inhibits proliferation via ERKs and phosphatidyl inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells (International Journal of Cancer (2002) 100 (642-653))

AU - Puricelli, L.

AU - Proietti, Cecilia J.

AU - Labriola, L.

AU - Salatino, M.

AU - Balana, M. E.

AU - Aguirre Ghiso, J.

AU - Lupu, R.

AU - Pignataro, O. P.

AU - Charreau, E. H.

AU - Bal De Kier Joffe, E.

AU - Elizalde, P. V.

PY - 2005/12/20

Y1 - 2005/12/20

UR - http://www.scopus.com/inward/record.url?scp=28044463403&partnerID=8YFLogxK

U2 - 10.1002/ijc.21414

DO - 10.1002/ijc.21414

M3 - Comment/debate

AN - SCOPUS:28044463403

SN - 0020-7136

VL - 117

SP - 1065

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 6

ER -

Puricelli L, Proietti CJ, Labriola L, Salatino M, Balana ME, Aguirre Ghiso J et al. Erratum: Heregulin inhibits proliferation via ERKs and phosphatidyl inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells (International Journal of Cancer (2002) 100 (642-653)). International Journal of Cancer. 2005 Dec 20;117(6):1065. doi: 10.1002/ijc.21414